A 340B program advocate this week condemned a new GOP U.S. House bill that would prohibit covered entities from using [...] …
Articles by : Shannon Young, Associate Editor/Senior Writer
The manufacturers behind 15 drugs selected for the second round of Medicare drug price negotiations under the Inflation Reduction Act [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The 340B drug pricing program is drawing newfound national media attention following recent articles on a multistate dark money ad [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Mehmet Oz, the celebrity heart surgeon and former U.S. Senate candidate that President Donald Trump nominated to lead the Centers [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Although misinformation accounts for just 2% of the overall 340B conversations taking place online, “conspiratorial narratives” driven by conservative influencers—and [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Washington D.C. dark money group with White House ties recently upped its attacks on 340B contract pharmacy access bills [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A U.K.-based drug giant this week moved to add three specialty cancer treatment medications to its list of drugs subject [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Chicago-based drugmaker recently added two new medications to its growing list of drugs subject to 340B contract pharmacy restrictions. [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Several drugmakers recently notified covered entities of changes to their 340B drug ceiling prices, resulting in refunds, while others announced [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The budget reconciliation process and President Donald Trump’s (R) priorities are expected to continue dominating Washington D.C. politics in the [...] …